APA (7th ed.) Citation

Makoto Fujiwara, Makoto Fujiwara, Masaru Shimizu, Masaru Shimizu, Tatsuya Okano, Yuko Maejima, & Kenju Shimomura. (2023). Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: A case report and systematic review. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Makoto Fujiwara, Makoto Fujiwara, Masaru Shimizu, Masaru Shimizu, Tatsuya Okano, Yuko Maejima, and Kenju Shimomura. Successful Treatment of Nivolumab and Ipilimumab Triggered Type 1 Diabetes by Using Sodium-glucose Transporter 2 Inhibitor: A Case Report and Systematic Review. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Makoto Fujiwara, et al. Successful Treatment of Nivolumab and Ipilimumab Triggered Type 1 Diabetes by Using Sodium-glucose Transporter 2 Inhibitor: A Case Report and Systematic Review. Frontiers Media S.A., 2023.